HER2 Support Group Forums - View Single Post - EMEA grants orphan drug designation for pixantrone in Europe

News · 12-21-2009, 12:40 AM

Cell Therapeutics, Inc. ("CTI") announced today that the European Medicines Agency (EMEA) has granted pixantrone orphan drug designation for the treatment of DLBCL which accounts for about 80% of aggressive non-Hodgkin's lymphoma.

More...

12-21-2009, 12:40 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,156	EMEA grants orphan drug designation for pixantrone in Europe Cell Therapeutics, Inc. ("CTI") announced today that the European Medicines Agency (EMEA) has granted pixantrone orphan drug designation for the treatment of DLBCL which accounts for about 80% of aggressive non-Hodgkin's lymphoma. More...